v3.26.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2026
Summary of Significant Accounting Policies [Abstract]  
Schedule of Financial Assets and Liabilities Based on Fair Value Measurement Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

    Fair value measurements at reporting date using:  
    Fair value     Quoted prices in active markets for identical liabilities
(Level 1)
    Significant other observable inputs
(Level 2)
    Significant unobservable inputs
(Level 3)
 
Assets:                        
Cash equivalents, June 30, 2026   $ 8,882,106     $ 8,882,106     $       -     $ -  
Cash equivalents, December 31, 2025   $ 7,031,708     $ 7,031,708     $ -     $ -  
                                 
Liabilities:                                  
Representative warrant liabilities, June 30, 2026   $ 5,899,561     $ -     $ -     $ 5,899,561  
Representative warrant liabilities, December 31, 2025   $ 53,000     $ -     $ -     $ 53,000  
Schedule of Reconciliation of the Level 3 Representative Warrants Liabilities

The following tables present a reconciliation of the Level 3 Warrants liabilities:

 

    For the Three Months Ended
June 30,
 
    2026     2025  
Representative warrant liabilities, April 1   $ 7,714,794     $ 10,971  
Additions         -       -  
Change in fair value       (1,815,233 )     121,476  
Representative warrant liabilities, June 30   $ 5,899,561     $ 132,447  
    For the Six Months Ended
June 30,
 
    2026     2025  
Representative warrant liabilities, January 1   $ 53,000     $ 24,486  
Additions         5,347,441       -  
Change in fair value       499,120       107,961  
Representative warrant liabilities, June 30   $ 5,899,561     $ 132,447  
Schedule of Fair Value of the Warrants In determining the fair value of the warrants, the Company used the following inputs as of June 30, 2026:
Risk-free interest rate     4.19 %
Expected dividend yield     0 %
Expected volatility     129.18 %
Expected life     4.6 years  
Schedule of Net Loss Per Share Calculation

The following table details the net loss per share calculation, reconciles between basic and diluted weighted average shares outstanding, and presents the potentially dilutive shares that are excluded from the calculation of the weighted average diluted common shares outstanding, because their inclusion would have been anti-dilutive:

 

    For the Three Months Ended     For the Six Months Ended  
    June 30,     June 30,  
    2026     2025     2026     2025  
Numerator:                        
Net loss   $ (3,685,060 )   $ (4,093,231 )   $ (17,542,263 )   $ (6, 327,213 )
Weighted-average common shares outstanding, basic and diluted     126,521,134       33,952,418       109,946,717       30,755,807  
Basic and diluted loss per share   $ (0.03 )   $ (0.12 )   $ (0.16 )   $ (0.21 )
Schedule of Weighted Average Common Shares Outstanding

The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive:

 

    As of June 30,  
    2026     2025  
Warrants     44,622,757       12,030,000  
Preferred Shares C (1)     47,940       -  
Total potentially dilutive shares     44,670,697       12,030,000  

 

(1) The 47,940 shares of Series C Preferred Stock outstanding at June 30, 2026 are each convertible into 42,554 shares of common stock, or 2,040,038,760 shares of common stock in the aggregate, only upon approval by the Company’s stockholders. Such approval had not been obtained as of June 30, 2026, and accordingly the Series C Preferred Stock was not convertible and is excluded from the computation of diluted net loss per share. See Note 10.